« Previous
Next »
European Journal of Radiology
Volume 75, Issue 2
, Pages 143-146
, August 2010
Dual-time point scanning of integrated FDG PET/CT for the evaluation of mediastinal and hilar lymph nodes in non-small cell lung cancer diagnosed as operable by contrast-enhanced CT
References
- Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 1992;182:319–323
- CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178:705–713
- . Is there a role for routine mediastinoscopy in patients with peripheral T1 lung cancers?. Am J Surg. 2000;180:488–492
- Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest. 2006;130:710–718
- . Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg. 1995;110:130–139
- Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Eng J Med. 2003;348:2500–2507
- . Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours. Eur J Nucl Med Mol Imaging. 2004;31:202–207
- Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol. 1998;16(6):2142–2149
- . Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med. 2002;43:871–875
- 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540–548
- . Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–1723
- Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin Nucl Med. 2007;32(2):101–105
- . Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-d-glucose. J Nucl Med. 1978;19:1154–1161
- Advantage of delayed whole-body FDG-PET imaging for tumour detection. Eur J Nucl Med. 2001;28:696–703
- . Limitations of dual time point FDG-PET imaging in the evaluation of focal abdominal lesions. Nuklearmedizin. 2004;43:143–149
- Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?. Eur J Nucl Med Mol Imaging. 2005;32(5):541–548
- Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. Eur J Nucl Med. 1999;26:1345–1348
- Delayed 18F-fluoro-2-deoxy-d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer. 2000;89:2547–2554
PII: S0720-048X(09)00227-7
doi: 10.1016/j.ejrad.2009.04.044
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
European Journal of Radiology
Volume 75, Issue 2
, Pages 143-146
, August 2010
